BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2431659)

  • 21. 1,25-Dihydroxyvitamin D3 increased beta-adrenergic adenylate cyclase response of fetal rat keratinizing epidermal cells (FRSK cells).
    Takahashi H; Tamura T; Iizuka H
    J Dermatol Sci; 1996 Feb; 11(2):121-8. PubMed ID: 8869032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hydrocortisone on the adrenaline-adenylate cyclase system of the skin.
    Iizuka H; Kamigaki K; Nemoto O; Aoyagi T; Miura Y
    Br J Dermatol; 1980 Jun; 102(6):703-10. PubMed ID: 6252937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine (H2) receptor-adenylate cyclase system in pig skin (epidermis).
    Iizuka Hadachi K; Halprin KM; Levine V
    Biochim Biophys Acta; 1976 Jun; 437(1):150-7. PubMed ID: 7311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenylate cyclase system of human trichilemmoma cell line.
    Tsutsui M; Iizuka H; Ohkawara A; Adachi K; Kanzaki T
    Arch Dermatol Res; 1987; 279(8):530-5. PubMed ID: 2449140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
    Matsumoto T; Uchida T
    J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glucocorticoids on the beta-adrenergic adenylate cyclase system of pig skin.
    Iizuka H; Ohkawara A
    J Invest Dermatol; 1983 Jun; 80(6):524-8. PubMed ID: 6304200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
    Hepp KD; Renner R; Langley J; Häring HU
    Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase.
    Inamasu M; Totsuka T; Ikeo T; Nagao T; Takeyama S
    Biochem Pharmacol; 1987 Jun; 36(12):1947-54. PubMed ID: 3036156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
    Gabbay RA; Lardy HA
    FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of trypsin on the cyclic AMP system of the pig skin.
    Iizuka H; Aoyagi T; Kamigaki K; Kato N; Nemoto O; Miura Y
    J Invest Dermatol; 1981 Jun; 76(6):511-3. PubMed ID: 6263981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradykinin-dependent activation of adenylate cyclase activity and cyclic AMP accumulation in tracheal smooth muscle occurs via protein kinase C-dependent and -independent pathways.
    Stevens PA; Pyne S; Grady M; Pyne NJ
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):233-9. PubMed ID: 8280104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal adenylate cyclase: stimulation of the histamine (H2) receptor by tolazoline.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1977 Nov; 69(5):442-45. PubMed ID: 198480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new synthetic retinoid, E-5166, augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Watanabe M; Ohkawara A
    Acta Derm Venereol; 1985; 65(6):459-64. PubMed ID: 2420107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in response of psoriatic epidermis in cyclic AMP accumulation against certain adenyl cyclase agonists.
    Yoshikawa K; Mori N; Hadame K; Sakakibara S
    Acta Derm Venereol; 1980; 60(2):95-98. PubMed ID: 6155039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine activation of pig skin adenylate cyclase in vivo and subsequent refractoriness to activation.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1978 Mar; 70(3):119-22. PubMed ID: 204708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in the levels of cyclic adenosine 3':5'-monophosphate and in the activities of adenylate cyclase and cyclic adenosine 3':5'-monophosphate phosphodiesterase during aerobic morphogenesis of Mucor rouxii.
    Cantore ML; Galvagno MA; Passeron S
    Arch Biochem Biophys; 1980 Feb; 199(2):312-20. PubMed ID: 6244775
    [No Abstract]   [Full Text] [Related]  

  • 37. Melittin-induced alteration of epidermal adenylate cyclase responses.
    Kajita S; Iizuka H
    Acta Derm Venereol; 1987; 67(4):295-300. PubMed ID: 2445146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic GMP system in the epidermis.
    Adachi K; Aoyagi T; Iizuka H; Halprin KM; Levin V
    Curr Probl Dermatol; 1980; 10():39-65. PubMed ID: 6263550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoids increase the response of guinea pig but not human keratinocytes to agonists of adenylate cyclase in vitro.
    Wilkinson DI; Orenberg EK
    Arch Dermatol Res; 1983; 275(3):147-51. PubMed ID: 6311115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of novel synthesized retinobenzoic acid (Am-80) on adenylate cyclase and arachidonic acid release in pig epidermis.
    Koizumi H; Sato KC; Ohkawara A
    J Dermatol Sci; 1992 Mar; 3(2):97-102. PubMed ID: 1318072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.